Structure Therapeutics Inc. American Depositary Shares (GPCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.33B
Last updated: Nov 17, 2026 at 4:36 PM ET
Structure Therapeutics Inc. American Depositary Shares (GPCR) Statistics
Structure Therapeutics Inc. American Depositary Shares (GPCR) has a market cap of $1.33B. Its share count is up 24.57% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $1.33B |
|---|---|
| Latest price (Nov 17, 2026) | $18.17 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 50.65% over 52 weeks and trades 32.38% below its 50-day average.
| Beta (1Y) | 1.29 |
|---|---|
| 52-Week Change | -50.65% |
| 1-Month Change | -17.45% |
| 3-Month Change | -66.43% |
| 6-Month Change | -49.36% |
| Total Return (1Y) | -50.65% |
| Total Return (3Y CAGR) | -30.34% |
| Return vs SPY (1Y) | -58.89% |
| Max Drawdown (1Y) | -80.63% |
| Max Drawdown (3Y) | -80.63% |
| Sharpe Ratio (1Y) | -0.69 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $26.87 |
| 200-Day Average | $44.90 |
| 52-Week Range | $18.38 to $94.90 |
| RSI (14 Days) | 27.6 |
| Average Volume (20 Days) | 926.24K |
Financial Position
Current assets cover 11.91x current liabilities.
| Current Ratio | 11.91x |
|---|---|
| Quick Ratio | 11.91x |
Returns and Efficiency
Return on equity is -24.07% and return on assets is -22.04% over the last 12 months.
| Return on Equity (ROE) | -24.07% |
|---|---|
| Return on Assets (ROA) | -22.04% |
| Return on Capital Employed (ROCE) | -23.90% |
| ROA (5Y Average) | -25.90% |
| ROIC (5Y Average) | 12.84% |
Scores
GPCR has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$340.62M |
| Pretax Income | -$293.34M |
| Net Income | -$294.11M |
| EBITDA | -$291.74M |
| EBIT | -$293.34M |
| Reported EPS (TTM) | -$1.99 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 91.73% of the $1.33B in total assets.
| Cash and Equivalents | $222.03M |
|---|---|
| Working Capital | $1.17B |
| Shareholder Equity | $1.22B |
| Total Assets | $1.33B |
| Total Liabilities | $112.55M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $6.37M of capital spending, operating cash flow left -$277.32M of free cash flow.
| Operating Cash Flow | -$270.95M |
|---|---|
| Capital Expenditures | $6.37M |
| Free Cash Flow | -$277.32M |
| FCF Per Share | -$3.87 |
| Depreciation and Amortization | $1.60M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
GPCR does not pay a dividend. Its free cash flow yield is -20.95%.
| FCF Yield | -20.95% |
|---|---|
| Shareholder Yield | 0.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GPCR
What is GPCR's market cap?
Structure Therapeutics Inc. American Depositary Shares has a market cap of $1.33B.
How many shares of GPCR are outstanding?
Structure Therapeutics Inc. American Depositary Shares has 72.86M shares outstanding. The count is up 24.57% from a year earlier.
Does GPCR pay a dividend?
No. Structure Therapeutics Inc. American Depositary Shares does not pay a dividend.
GPCR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors